UPDATE 1-U.S. Supreme Court rules for Teva over multiple sclerosis drug patent

WASHINGTON, Jan 20 (Reuters) - The U.S. Supreme Court on Tuesday ruled for Teva Pharmaceutical Industries Ltd in its fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug, by sending the case back to a lower court for further review.